Phase 2 Readout

Phase 2 Readout: tafenoquine

SXTP overview →Track this catalyst
Indication
severe babesiosis

Other upcoming events for SXTP

Phase 2 ReadoutPhase 2 Readout: tafenoquine
Patent ExpiryPatent/Exclusivity Expiry: ARAKODA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

  • 200 free AI credits / month to run live multi-agent analysis
  • Watchlist, catalyst alerts & the biotech event calendar
  • Full pipeline, financials & FDA data on every company
Start Free
    Phase 2 Readout: tafenoquine — SXTP Phase 2 Readout | BioSniper